Skip to main content

Table 1 Relationship of miRNA let-7i expression level and clinicopathological features

From: Decreased expression of microRNA let-7i and its association with chemotherapeutic response in human gastric cancer

Factors

Number of patients

Let-7i (Average fold change ± SD)

P value

Age (years)

≤59

43

0.33 ± 0.14

0.388

#62;59

43

0.26 ± 0.19

 

Sex

Male

57

0.38 ± 0.35

0.215

Female

29

0.24 ± 0.16

 

Local invasion

T2

19

0.87 ± 0.71

<0.001 a

T3

35

0.40 ± 0.25

0.002 b

T4

32

0.13 ± 0.11

 

Lymphatic metastasis

N1

33

0.49 ± 0.44

0.003

N2

53

0.18 ± 0.15

 

Tumor site

Upper

22

0.35 ± 0.30

0.262

Middle

30

0.25 ± 0.23

 

Lower

34

0.30 ± 0.22

 

Cell grade

Poor

60

0.27 ± 0.18

0.476

Moderate

26

0.32 ± 0.28

 

Pathologic tumor response

Responder

55

0.59 ± 0.46

<0.001

Non-responder

31

0.16 ± 0.10

 
  1. a Compared with T3 and T4; b Compared with T4.